These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine. Mackow N, Amaro-Carambot E, Liang B, Surman S, Lingemann M, Yang L, Collins PL, Munir S. J Virol; 2015 Oct 01; 89(20):10319-32. PubMed ID: 26223633 [Abstract] [Full Text] [Related]
18. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein. Cimica V, Boigard H, Bhatia B, Fallon JT, Alimova A, Gottlieb P, Galarza JM. Clin Vaccine Immunol; 2016 Jun 01; 23(6):451-9. PubMed ID: 27030590 [Abstract] [Full Text] [Related]
19. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, Boukhvalova MS, Gilbert BE, Blanco JC, Piedra PA, Wright ER, Moore ML. Nat Commun; 2016 Dec 21; 7():13916. PubMed ID: 28000669 [Abstract] [Full Text] [Related]